TME Pharma NV (FRA:0N6A) EPS (Basic) : €-0.36 (TTM As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is TME Pharma NV EPS (Basic)?

TME Pharma NV's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was €-0.09. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.36.

TME Pharma NV's EPS (Diluted) for the six months ended in Jun. 2024 was €-0.09. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.36.

TME Pharma NV's EPS without NRI for the six months ended in Jun. 2024 was €-0.09. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was -0.36.

During the past 3 years, the average EPS without NRI Growth Rate was 64.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 50.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, TME Pharma NV's highest 3-Year average EPS without NRI Growth Rate was 77.30% per year. The lowest was -22.50% per year. And the median was 49.90% per year.

TME Pharma NV EPS (Basic) Historical Data

The historical data trend for TME Pharma NV's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TME Pharma NV EPS (Basic) Chart

TME Pharma NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-5.32

-22.08

-15.11

-9.79

-1.02

TME Pharma NV Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EPS (Basic)	Get a 7-Day Free Trial														-7.91	-1.88	-0.75	-0.27	-0.09

TME Pharma NV EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

TME Pharma NV's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-6.736	-	0)	/	6.593
	=	-1.02

TME Pharma NV's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-3.248	-	0)	/	35.929
	=	-0.09

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.36

TME Pharma NV (FRA:0N6A) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

TME Pharma NV EPS (Basic) Related Terms

Thank you for viewing the detailed overview of TME Pharma NV's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

TME Pharma NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TME Pharma NV (FRA:0N6A) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

ALTME:France 0N6A:Germany

Address

Max-Dohrn-Street 8-10, Berlin, DEU, 10589

Website

https://www.tmepharma.com

TME Pharma NV is a clinical-stage biopharmaceutical company engaged in improving cancer treatment by targeting the tumor microenvironment and focusing on the improvement in the effectiveness of cancer therapies. Its product candidates are; NOX-A12 and NOX-E36 are based on a new class of drug first developed by TME Pharma called Spiegelmers, which offer specific advantages over other drug classes.

TME Pharma NV Headlines

No Headlines